Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation

Int J Tuberc Lung Dis. 2016 Sep;20(9):1275-6. doi: 10.5588/ijtld.16.0148.

Authors

Ralf Otto-Knapp¹, Silvan Vesenbeckh², Nicolas Schönfeld², Gudrun Bettermann³, Andreas Roth⁴, Torsten Bauer¹, Holger Rüssmann³, Harald Mauch³

Affiliations

¹ Department of Pneumology, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, German Central Committee against Tuberculosis (DZK), Germany.
² Department of Pneumology, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Germany.
³ Institute of Microbiology, HELIOS Klinikum Emil von Behring, Germany.
⁴ Institute of Molecular Biology, HELIOS Klinikum Emil von Behring, Berlin, Germany.

PMID: 27510258
DOI: 10.5588/ijtld.16.0148

No abstract available

Publication types

Letter

MeSH terms

Antitubercular Agents / administration & dosage
Antitubercular Agents / pharmacology*
Bacterial Proteins / genetics*
Catalase / genetics*
Humans
Isoniazid / administration & dosage
Isoniazid / pharmacology*
Microbial Sensitivity Tests
Mutation
Mycobacterium tuberculosis / drug effects*
Mycobacterium tuberculosis / genetics
Mycobacterium tuberculosis / isolation & purification
Retrospective Studies
Tuberculosis / drug therapy
Tuberculosis / microbiology

Substances

Antitubercular Agents
Bacterial Proteins
Catalase
katG protein, Mycobacterium tuberculosis
Isoniazid